Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus

BACKGROUND: Zika virus (ZIKV) infection is a global health problem, and its complications, including congenital Zika syndrome and Guillain-Barré syndrome, constitute a continued threat to humans. Unfortunately, effective therapeutics against ZIKV infection are not available thus far. METHODS: We scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jie, Yu, Jianchen, Huang, Yun, He, Zhenjian, Luo, Jia, Wu, Yun, Zheng, Yingchun, Wu, Jueheng, Zhu, Xun, Wang, Haihe, Li, Mengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392643/
https://www.ncbi.nlm.nih.gov/pubmed/32731873
http://dx.doi.org/10.1186/s12916-020-01663-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392643/
https://www.ncbi.nlm.nih.gov/pubmed/32731873
http://dx.doi.org/10.1186/s12916-020-01663-1

Ejemplares similares